These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31604180)

  • 1. Biorelevant polyanions stabilize fibrin against mechanical and proteolytic decomposition: Effects of polymer size and electric charge.
    Komorowicz E; Balázs N; Tanka-Salamon A; Varga Z; Szabó L; Bóta A; Longstaff C; Kolev K
    J Mech Behav Biomed Mater; 2020 Feb; 102():103459. PubMed ID: 31604180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size- and charge-dependent modulation of the lytic susceptibility and mechanical stability of fibrin-histone clots by heparin and polyphosphate variants.
    Komorowicz E; Balázs N; Tanka-Salamon A; Varga Z; Szabó L; Bóta A; Longstaff C; Kolev K
    J Thromb Haemost; 2021 May; 19(5):1307-1318. PubMed ID: 33609065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid decreases the mechanical stability, but increases the lytic resistance of fibrin matrices.
    Komorowicz E; Balázs N; Varga Z; Szabó L; Bóta A; Kolev K
    Matrix Biol; 2017 Nov; 63():55-68. PubMed ID: 28007568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA and histones impair the mechanical stability and lytic susceptibility of fibrin formed by staphylocoagulase.
    Komorowicz E; Farkas VJ; Szabó L; Cherrington S; Thelwell C; Kolev K
    Front Immunol; 2023; 14():1233128. PubMed ID: 37662916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin structure, viscoelasticity and lysis face the interplay of biorelevant polyions.
    Komorowicz E; Kolev K
    Curr Opin Hematol; 2022 Sep; 29(5):244-250. PubMed ID: 35916559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyphosphate nanoparticles enhance the fibrin stabilization by histones more efficiently than linear polyphosphates.
    Lovas M; Tanka-Salamon A; Beinrohr L; Voszka I; Szabó L; Molnár K; Kolev K
    PLoS One; 2022; 17(4):e0266782. PubMed ID: 35468161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
    Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
    Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
    Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
    Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems.
    Longstaff C; Hogwood J; Gray E; Komorowicz E; Varjú I; Varga Z; Kolev K
    Thromb Haemost; 2016 Mar; 115(3):591-9. PubMed ID: 26632486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones.
    Longstaff C; Varjú I; Sótonyi P; Szabó L; Krumrey M; Hoell A; Bóta A; Varga Z; Komorowicz E; Kolev K
    J Biol Chem; 2013 Mar; 288(10):6946-56. PubMed ID: 23293023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphosphate enhances fibrin clot structure.
    Smith SA; Morrissey JH
    Blood; 2008 Oct; 112(7):2810-6. PubMed ID: 18544683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
    Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
    Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex.
    Chang GMT; Atkinson HM; Berry LR; Chan AKC
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):431-437. PubMed ID: 27898513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
    Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Histones Inhibit Fibrinolysis through Noncovalent and Covalent Interactions with Fibrin.
    Locke M; Longstaff C
    Thromb Haemost; 2021 Apr; 121(4):464-476. PubMed ID: 33131044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From
    Farkas ÁZ; Farkas VJ; Szabó L; Wacha A; Bóta A; Csehi L; Kolev K; Thelwell C
    Front Immunol; 2019; 10():2967. PubMed ID: 31921206
    [No Abstract]   [Full Text] [Related]  

  • 18. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
    Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
    J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis.
    Meh DA; Mosesson MW; DiOrio JP; Siebenlist KR; Hernandez I; Amrani DL; Stojanovich L
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):627-37. PubMed ID: 11734662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.